NL-OMON44528Not yet recruitingNot Applicable
Blood biomarkers in frontotemporal dementia: a longitudinal study - Longitudinal blood biomarkers in frontotemporal dementia
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites80 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients with frontotemporal dementia who visited our referral centre and were diagnosed according to International Consensus Criteria. All clinical subtypes will be included, both genetic and sporadic.
Exclusion Criteria
- •Patients with a history of unrelated neurological disorders that could influence cognitive performance (such as normal pressure hydrocephalus, brain tumours, developmental disorders et cetera).
Investigators
Similar Trials
Recruiting
Not Applicable
Establishment of brain bank and blood/cerebrospinal fluid-based reference laboratory for diagnosis of dementiaDiseases of the nervous systemKCT0004695Pusan National University Hospital115
Completed
Not Applicable
Establishment of brain bank and blood/cerebrospinal fluid-based reference laboratory for diagnosis of dementiaDiseases of the nervous systemKCT0004635Pusan National University Hospital20
Completed
Not Applicable
The utility of blood-based biomarkers for Alzheimer*s disease in memory Cliniccognitieve impairment10011305DementiaNL-OMON51700Medisch Centrum Leeuwarden400
Active, not recruiting
Phase 1
Imaging of neuroinflammation in frontotemporal dementia by means of PET-MRIFrontotemporal dementia (FTD), including symptomatic patients and presymptomatic individuals with genetic mutations predisposing to FTD at a later stage in life.EUCTR2020-002672-12-NLErasmus Medical Center32
Recruiting
Not Applicable
Frontotemporal dementia Imaging of Neuroinflammation, Degeneration and Microglia-Related Effects1004225810012272Frontotemporal dementiaFTDNL-OMON49263Erasmus MC, Universitair Medisch Centrum Rotterdam32